tiprankstipranks
Inmune Bio Inc (INMB)
NASDAQ:INMB
Holding INMB?
Track your performance easily

Inmune Bio (INMB) Financial Statements

333 Followers

Inmune Bio Financial Overview

Inmune Bio's market cap is currently ―. The company's EPS TTM is $-2.183; its P/E ratio is -2.09; Inmune Bio is scheduled to report earnings on February 27, 2025, and the estimated EPS forecast is $-0.56. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue--$ 14.00K$ 28.00K$ 43.00K
Gross Profit--$ 14.00K$ 28.00K$ 43.00K
EBIT$ -11.95M$ -9.50M$ 10.68M$ -8.38M$ -8.00M
EBITDA$ -11.93M$ -9.47M$ 10.71M$ -8.38M$ -7.94M
Net Income Common Stockholders$ -12.09M$ -9.75M$ -11.00M$ -8.41M$ -8.56M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 33.55M$ 31.07M$ 26.00M$ 35.85M$ 41.81M
Total Assets$ 52.78M$ 52.45M$ 46.83M$ 57.00M$ 62.70M
Total Debt$ 2.91M$ 5.43M$ 7.94M$ 10.44M$ 12.91M
Net Debt$ -30.64M$ -25.64M$ -18.06M$ -25.41M$ -28.90M
Total Liabilities$ 14.11M$ 16.03M$ 17.81M$ 18.86M$ 17.97M
Stockholders Equity$ 38.67M$ 36.28M$ 28.22M$ 37.34M$ 43.93M
Cash Flow-
Free Cash Flow$ -6.90M$ -7.90M$ -7.50M$ -3.40M$ -4.26M
Operating Cash Flow$ -6.90M$ -7.90M$ -7.50M$ -3.40M$ -4.26M
Investing Cash Flow-----
Financing Cash Flow$ 9.79M$ 13.00M$ -2.50M$ -2.50M$ -1.73M
Currency in USD

Inmune Bio Earnings and Revenue History

Inmune Bio Debt to Assets

Inmune Bio Cash Flow

Inmune Bio Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis